W hether in search of relatives, a family's country of origin, or to understand personal disease risk, 15 million people have ...

Me's financial troubles may lead to customers' genetic data exchanging hands if an acquisition occurs. Here's how to delete ...

On Thursday, 23andMe Holding Co. (ME) stock saw a modest uptick, ending the day at $0.39 which represents no change from the prior close of $0.39. The stock opened at $0.39 and touched a low of $0.37 ...

After 23andMe’s board of directors resigns, the president of encrypted messaging app Signal joins other security experts in ...

Genetic surveillance company 23andMe, once a $6bn prospect, is now a penny stock on the verge of doom. So "what happens to ...

DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...

The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...

23andMe is in trouble. Once a hot Silicon Valley startup, the genetic testing company has been in free fall since a major ...

This report was created with support from enhanced software. Genetic testing company 23andMe has agreed to a $30 million settlement after a data breach exposed the personal information of ...

DNA might contain health information, but unlike a doctor’s office, 23andMe is not bound by the health-privacy law HIPAA. And ...

Once a hot $6 billion biotech company, 23andMe is now on the verge of collapse. What could happen to the DNA data of its 14 million customers?

In April, a Securities and Exchange Commission filing revealed that Wojcicki planned to take the company private. 23andMe’s stock price had fallen below $1 per share at the time, down from its $10 ...